Horizon Bancorp’s Quest Diagnostics DGX Stock Holding History

Horizon Bancorp’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-116	Closed	-$12K	–	278
2019 Q4	$12K	Buy	+116	New	+$12.1K	0.01%	235

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Horizon Bancorp's DGX Position: Q1 2020 in Review

Horizon Bancorp sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 116 shares — an estimated $12K sold.

Horizon Bancorp first reported a position in DGX in Q4 2019 and held it in 1 quarter. The position peaked at $12K in Q4 2019. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

Horizon Bancorp reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
Horizon Bancorp sold 116 Quest Diagnostics shares in Q1 2020, an estimated $12K.
Horizon Bancorp first reported a position in Quest Diagnostics in Q4 2019 and held it in 1 quarter.
Horizon Bancorp's Quest Diagnostics position peaked at $12K in Q4 2019.
714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Horizon Bancorp's 13F filing for Q1 2020, filed 20 Apr 2020.